Kenneth Dominic Abreo, MBBS

Kenneth Abreo practices at Ochsner LSU Health - Academic Medical Center in Shreveport, Louisiana, part of Ochsner Health System.

Kenneth Abreo's NPI, 1750303145, was assigned on July 24, 2006. Kenneth Abreo holds Louisiana license 06699R.

Kenneth Abreo's primary practice is Ochsner LSU Health - Academic Medical Center, at 1541 Kings Highway, Shreveport, LA 71130 in Caddo Parish. The practice phone is (318) 675-5058.

Kenneth Abreo's primary practice is Ochsner LSU Health - Academic Medical Center in Shreveport, Louisiana, part of Ochsner Health System. The medical group on file is LSU Health Shreveport. Dmand AI also links Kenneth Abreo to 4 more dialysis centers, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Kenneth Abreo practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Kenneth Abreo's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Kenneth Abreo is licensed in Louisiana.

Dmand AI lists acute kidney failure, chronic kidney disease and fluid and electrolyte imbalances among the conditions Kenneth Abreo treats.

CMS data shows 16 Medicare services from Kenneth Abreo across 1 procedure code in 2024, all of them office visits, for 39 Medicare patients. Medicare paid $1,322 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 39 Medicare patients who saw Kenneth Abreo in 2024. The largest group is 65 to 74, with 17 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 38% are also on Medicaid. Their average risk score is 3.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Kenneth Abreo's median patient age at 69, with 56% women.

In 2024, Kenneth Abreo wrote 492 Medicare Part D claims for 133 patients. 72% of them were for generic drugs. CMS names the drug for 323 of them, across 11 drugs with 11 or more claims each, at $127,664 in total drug cost. In 2023, CMS named 684 claims across 17 drugs.

Kenneth Abreo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 37 papers to Kenneth Abreo, published from 2010 to 2023. 2021 was the busiest year, with 5. The most frequent topics are Renal Dialysis, Arteriovenous Shunt, Surgical and Kidney Failure, Chronic. Kenneth Abreo has published most often in J Vasc Access. Kenneth Abreo's most frequent co-authors are Adrian Sequeira, MD, Adrian Paul Abreo, MD and Loay H. Salman, MD.

Dmand AI links Kenneth Abreo to 1 clinical trial. Conditions studied include Arteriovenous Fistula and Vascular Fistula. Open Payments lists research payments to Kenneth Abreo that name 1 trial.

CMS Open Payments shows 360 general payments to Kenneth Abreo from 32 drug and device companies from 2016 to 2025. Honoraria make up the largest share, 67% of the total. Calliditas Therapeutics US Inc. paid the most, $37,361. It also lists 3 research payments totaling $4,500 from 2016 to 2017, naming 1 clinical trial.

Kenneth Abreo is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.